Losartan Potassium
Product Images NDC 53002-2643

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-2643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (92296151 E507 41b4 A040 C01b87ecb982 01)

FDA Label Image

Figure 2 (92296151 E507 41b4 A040 C01b87ecb982 02)

Figure 2 (92296151 E507 41b4 A040 C01b87ecb982 02)
This appears to be a graphical representation of data related to a study on the effectiveness of Atenolol and Losartan Potassium Tablets in reducing risk for some sort of primary endpoint. The data shows an "Adjusted Risk Reduction" of 13% with a p-value of 0.021. The x-axis appears to represent study months, while the y-axis may represent the percentage of patients with the primary endpoint. Without additional context or information, it is difficult to determine the exact nature of the study or the primary endpoint.*
FDA Label Image

Figure 3 (92296151 E507 41b4 A040 C01b87ecb982 03)

Figure 3 (92296151 E507 41b4 A040 C01b87ecb982 03)
The text appears to be a result comparison between Atenolol and Losartan Potassium Tablets for patients with fatal/non-fatal stroke indicating an adjusted risk reduction of 25% with a p-value of 0.001 over a period of study months ranging from 6 to 68.*
FDA Label Image

Figure 4 (92296151 E507 41b4 A040 C01b87ecb982 04)

FDA Label Image

Figure 5 (92296151 E507 41b4 A040 C01b87ecb982 05)

Figure 5 (92296151 E507 41b4 A040 C01b87ecb982 05)
This appears to be a table showing the percentage of patients with an event and some calculations for risk reduction. There is also a mention of losartan potassium tablets and a placebo, which may be related to the numbers in the table, but without more information it's difficult to know for sure.*
FDA Label Image

Figure 6 (92296151 E507 41b4 A040 C01b87ecb982 06)

FDA Label Image

Figure 6 (92296151 E507 41b4 A040 C01b87ecb982 07)

FDA Label Image

Label Image (Lbl530022643)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.